Published in Br J Cancer on April 01, 1999
So much to do, so little time: care for the socially disadvantaged and the 15-minute visit. Arch Intern Med (2008) 2.50
Promoting patient participation and shortening cancer consultations: a randomised trial. Br J Cancer (2001) 2.13
Communication in cancer genetic counselling: does it reflect counselees' previsit needs and preferences? Br J Cancer (2005) 1.13
Asking questions can help: development and preliminary evaluation of a question prompt list for palliative care patients. Br J Cancer (2003) 1.12
Using health communication best practices to develop a web-based provider-patient communication aid: the CONNECT study. Patient Educ Couns (2008) 1.05
Identifying patient information needs about cancer clinical trials using a Question Prompt List. Patient Educ Couns (2010) 1.05
Part II, provider perspectives: should patients be activated to request evidence-based medicine? A qualitative study of the VA project to implement diuretics (VAPID). Implement Sci (2010) 1.04
Low-literacy interventions to promote discussion of prostate cancer: a randomized controlled trial. Am J Prev Med (2007) 1.03
An intervention to promote patient participation and self-management in long term conditions: development and feasibility testing. BMC Health Serv Res (2010) 1.00
Psychosocial determinants of cancer-related information seeking among cancer patients. J Health Commun (2011) 0.98
Effects of coaching patients with lung cancer to report cancer pain. West J Nurs Res (2010) 0.97
Older cancer patients' information and support needs surrounding treatment: An evaluation through the eyes of patients, relatives and professionals. BMC Nurs (2009) 0.97
Identifying and predicting subgroups of information needs among cancer patients: an initial study using latent class analysis. Support Care Cancer (2010) 0.95
Shared decision making in oncology: assessing oncologist behaviour in consultations in which adjuvant therapy is considered after primary surgical treatment. Health Expect (2010) 0.93
Training community resource center and clinic personnel to prompt patients in listing questions for doctors: follow-up interviews about barriers and facilitators to the implementation of consultation planning. Implement Sci (2008) 0.92
The importance of multidisciplinary team management of patients with non-small-cell lung cancer. Curr Oncol (2012) 0.91
Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer. Br J Cancer (2006) 0.90
Enhancing decision making about participation in cancer clinical trials: development of a question prompt list. Support Care Cancer (2010) 0.90
Using Argumentation Theory to Identify the Challenges of Shared Decision-Making when the Doctor and the Patient have a Difference of Opinion. J Public Health Res (2012) 0.90
Active patient participation in the development of an online intervention. JMIR Res Protoc (2014) 0.90
Assessment of palliative care cancer patients' most important concerns. Support Care Cancer (2010) 0.89
Testing the utility of a cancer clinical trial specific Question Prompt List (QPL-CT) during oncology consultations. Patient Educ Couns (2012) 0.89
A consultation leaflet to improve an older patient's involvement in general practice care: a randomized trial. Health Expect (2005) 0.84
Evaluation of question-listing at the Cancer Support Community. Transl Behav Med (2013) 0.83
Shared decision-making and comparative effectiveness research for patients with chronic conditions: an urgent synergy for better health. J Comp Eff Res (2013) 0.81
Awareness of genetic counseling and perceptions of its purpose: a survey of the Canadian public. J Genet Couns (2013) 0.81
Do patients use decision and communication aids as prompted when meeting with breast cancer specialists? Health Expect (2013) 0.80
Engaging Patients, Health Care Professionals, and Community Members to Improve Preoperative Decision Making for Older Adults Facing High-Risk Surgery. JAMA Surg (2016) 0.79
Physician endorsement alone may not enhance question-asking by advanced cancer patients during consultations about palliative care. Support Care Cancer (2011) 0.79
Evaluation of a pilot communication skills training intervention for minority cancer patients. J Psychosoc Oncol (2011) 0.78
Encouraging Patient-Centered Care by Including Quality-of-Life Questions on Pre-Encounter Forms. Ann Fam Med (2016) 0.77
INvolvement of breast CAncer patients during oncological consultations: a multicentre randomised controlled trial--the INCA study protocol. BMJ Open (2013) 0.76
Coaching patients in the use of decision and communication aids: RE-AIM evaluation of a patient support program. BMC Health Serv Res (2015) 0.75
A question prompt sheet for adult patients with chronic kidney disease. BMC Nephrol (2016) 0.75
Primary care providers' bereavement care practices: recommendations for research directions. Int J Geriatr Psychiatry (2014) 0.75
Randomized trial of a question prompt list to increase patient active participation during interactions with black patients and their oncologists. Patient Educ Couns (2016) 0.75
Improving clinical skills to support the emotional and psychological well-being of patients with end-stage renal disease: a qualitative evaluation of two interventions. Clin Kidney J (2016) 0.75
Patient-initiated questions: How can doctors encourage them and improve the consultation process? A qualitative study. BMJ Open (2013) 0.75
Information and participation preferences among cancer patients. Ann Intern Med (1980) 11.05
Changes in physicians' attitudes toward telling the cancer patient. JAMA (1979) 7.75
Gaps in doctor-patient communication. 1. Doctor-patient interaction and patient satisfaction. Pediatrics (1968) 7.47
Characteristics of physicians with participatory decision-making styles. Ann Intern Med (1996) 6.23
The prevalence of psychiatric disorders among cancer patients. JAMA (1983) 5.48
Patient participation in the patient-provider interaction: the effects of patient question asking on the quality of interaction, satisfaction and compliance. Health Educ Monogr (1977) 4.67
The relationship of physician medical interview style to patient satisfaction. J Fam Pract (1991) 4.38
What to tell cancer patients. A study of medical attitudes. JAMA (1961) 4.11
Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med (1988) 2.53
Breaking bad news: consensus guidelines for medical practitioners. J Clin Oncol (1995) 2.50
Physician behaviors, patient perceptions, and patient characteristics as predictors of satisfaction of hospitalized adult cancer patients. Cancer (1990) 2.12
Patient participation in the cancer consultation: evaluation of a question prompt sheet. Ann Oncol (1994) 2.09
Computer-based interaction analysis of the cancer consultation. Br J Cancer (1995) 1.93
Disclosure of breast cancer diagnosis: patient and physician reports. GIVIO (Interdisciplinary Group for Cancer Care Evaluation, Italy) Ann Oncol (1991) 1.87
Beyond medical paternalism and patient autonomy: a model of physician conscience for the physician-patient relationship. Ann Intern Med (1983) 1.59
Research and demonstration issues in self-care: measuring the decline of medicocentrism. Health Educ Monogr (1977) 1.23
The significance of the doctor-patient relationship in coping with cancer. Soc Sci Med (1984) 1.05
Words as scalpels: transmitting evidence in the clinical dialogue. Ann Intern Med (1980) 0.98
Evaluation of methods to improve communication in the physician-patient relationship. Am J Orthopsychiatry (1975) 0.90
Redressing the balance--the ethics of not entering an eligible patient on a randomised clinical trial. Ann Oncol (1992) 4.41
On the receiving end--patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol (1983) 4.35
Communicating prognosis in early breast cancer: do women understand the language used? Med J Aust (1999) 3.76
Randomised comparison of procedures for obtaining informed consent in clinical trials of treatment for cancer. Br Med J (Clin Res Ed) (1986) 3.52
The dynamics of change: cancer patients' preferences for information, involvement and support. Ann Oncol (1997) 3.50
Sharing decisions in cancer care. Soc Sci Med (2001) 2.70
Changing character of cervical cancer in young women. BMJ (1989) 2.66
Communication styles in the cancer consultation: preferences for a patient-centred approach. Psychooncology (2000) 2.59
Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. N Engl J Med (1987) 2.37
Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol (2001) 2.34
Promoting patient participation and shortening cancer consultations: a randomised trial. Br J Cancer (2001) 2.13
Communicating prognosis in cancer care: a systematic review of the literature. Ann Oncol (2005) 2.09
Patient participation in the cancer consultation: evaluation of a question prompt sheet. Ann Oncol (1994) 2.09
Lay constructions of decision-making in cancer. Psychooncology (2002) 2.03
The take-home message: patients prefer consultation audiotapes to summary letters. J Clin Oncol (1994) 2.03
On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol (1996) 2.03
Initial therapy with combination of five antibiotics in febrile patients with leukaemia and neutropenia. Lancet (1972) 1.96
Computer-based interaction analysis of the cancer consultation. Br J Cancer (1995) 1.93
Developing ethical strategies to assist oncologists in seeking informed consent to cancer clinical trials. Soc Sci Med (2004) 1.90
Physician-patient-companion communication and decision-making: a systematic review of triadic medical consultations. Patient Educ Couns (2013) 1.89
Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group. J Infect Dis (1978) 1.89
Letters to patients: improving communication in cancer care. Lancet (1991) 1.83
When the diagnosis is cancer: patient communication experiences and preferences. Cancer (1996) 1.82
Who should treat cancer? Lancet (1981) 1.81
Writing to referring doctors after a new patient consultation. What is wanted and what was contained in letters from one medical oncologist? Aust N Z J Med (1995) 1.75
Endocrine therapy for desmoid tumors. Cancer (1991) 1.61
Psychological responses of patients receiving a diagnosis of cancer. Ann Oncol (2003) 1.58
Association of lipids with integral membrane surface proteins of Mycoplasma hyorhinis. Infect Immun (1988) 1.58
Influence of cellular DNA content on survival in advanced ovarian cancer. Cancer Res (1984) 1.58
Triton X-114 phase fractionation of an integral membrane surface protein mediating monoclonal antibody killing of Mycoplasma hyorhinis. Infect Immun (1987) 1.55
Unknown primary adenocarcinoma: incidence of overinvestigation and natural history. Br Med J (1979) 1.54
General information tapes inhibit recall of the cancer consultation. J Clin Oncol (1993) 1.47
The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurrence of second malignancies in patients with breast cancer. International (Ludwig) Breast Cancer Study Group. Ann Oncol (1996) 1.41
Evaluation of the role of positron emission tomography in oncology. Med J Aust (2000) 1.38
Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients. Ann Oncol (2003) 1.38
Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration. Cancer Treat Rep (1982) 1.37
Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. Ann Oncol (2011) 1.36
Misunderstanding in cancer patients: why shoot the messenger? Ann Oncol (1999) 1.33
Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases. Cancer (1989) 1.33
Seeking informed consent to cancer clinical trials: describing current practice. Soc Sci Med (2004) 1.31
Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells. Br J Haematol (1976) 1.30
Hearing the bad news of a cancer diagnosis: the Australian melanoma patient's perspective. Ann Oncol (2001) 1.30
Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside. Br J Haematol (1974) 1.28
Immunohistochemical detection of proliferating cells in vivo. J Histochem Cytochem (1987) 1.22
Focus group interviews examining attitudes to randomised trials among breast cancer patients and the general community. Aust N Z J Public Health (1998) 1.21
Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer. J Clin Oncol (1999) 1.21
A randomized study: small cell anaplastic lung cancer treated by combination chemotherapy and adjuvant radiotherapy. Int J Radiat Oncol Biol Phys (1980) 1.21
Informed consent: what did the doctor say? Lancet (1999) 1.21
Informing breast cancer patients about clinical trials: a randomized clinical trial of an educational booklet. Ann Oncol (2002) 1.19
Seeking informed consent to cancer clinical trials; evaluating the efficacy of doctor communication skills training. Psychooncology (2007) 1.18
On the receiving end--II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy. Eur J Cancer Clin Oncol (1983) 1.17
What is important in cancer care coordination? A qualitative investigation. Eur J Cancer Care (Engl) (2011) 1.17
Counting the costs of cancer therapy. Eur J Cancer Clin Oncol (1982) 1.14
Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men. Arterioscler Thromb Vasc Biol (1997) 1.12
New approaches to cancer chemotherapy with methotrexate. N Engl J Med (1975) 1.12
Antibiotics and hypokalaemia. Lancet (1972) 1.12
Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy. Pathology (1984) 1.11
Cancer chemotherapy--what have we achieved? Lancet (1980) 1.10
The effect of external deoxyribonucleosides on deoxyribonucleoside triphosphate concentrations in human lymphocytes. Biochem Pharmacol (1975) 1.10
Pharmacokinetics of actinoymcin D in patients with malignant melanoma. Clin Pharmacol Ther (1975) 1.10
Women's preferences for discussion of prognosis in early breast cancer. Health Expect (2001) 1.09
Inflammatory pseudotumor of the liver causing biliary obstruction. Treatment by biliary stenting with 5-year follow-up. J Clin Gastroenterol (1991) 1.09
Improving patient outcomes through the routine use of patient-reported data in cancer clinics: future directions. Psychooncology (2009) 1.08
Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets. Q J Med (1987) 1.08
Properties of [99mTc] technetium-labelled liposomes in normal and tumour-bearing rats. Biochem Soc Trans (1977) 1.07
Communication and information-giving in high-risk breast cancer consultations: influence on patient outcomes. Br J Cancer (2004) 1.07
Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and complications. Arch Intern Med (1993) 1.05
Women's preferences and consultants' communication of risk in consultations about familial breast cancer: impact on patient outcomes. J Med Genet (2003) 1.04
Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group. Lancet (2001) 1.03
The emergence of drug resistance in tumours: a characteristic which may be exploited therapeutically. Br J Cancer (1973) 1.03
Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma. Br J Cancer (2000) 1.02
Flow cytometric and morphological studies of ovarian carcinoma cell lines and xenografts. Cancer Res (1983) 1.02
Discussing adjuvant cancer therapy. J Clin Oncol (2001) 1.02
Cancer by another name: a randomized trial of the effects of euphemism and uncertainty in communicating with cancer patients. J Clin Oncol (1993) 1.02
Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancer. Patient Educ Couns (2001) 1.01
Changes in the deoxyribonucleoside triphosphate pools of mouse 5178Y lymphoma cells following exposure to methotrexate or 5-fluorouracil. Cancer Res (1973) 1.01
Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer. Ann Oncol (2002) 1.00
Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry. Cancer Res (1981) 1.00
Tailoring communication in consultations with women from high risk breast cancer families. Br J Cancer (2002) 0.99
Changing patterns of infection in cancer patients. Eur J Cancer (1973) 0.99
Purine modulation of methotrexate cytotoxicity in mammalian cell lines. Cancer Res (1982) 0.99
Doing the best for the cancer patient. Lancet (1985) 0.99
The use of unproven methods of treatment by cancer patients. Frequency, expectations and cost. Support Care Cancer (1998) 0.98
Characteristics of cancer cell death after exposure to cytotoxic drugs in vitro. Br J Cancer (1996) 0.97
The reversal of methotrexate toxicity by thymidine with maintenance of antitumour effects. Nature (1975) 0.97
The context influences doctors' support of shared decision-making in cancer care. Br J Cancer (2007) 0.97